Previous CUIMC Grand Rounds
January 30, 2023
“In Science We Trust"
A discussion about the university’s role in communicating science to the public.
Moderated by
Linda P. Fried, MD, MPH
Dean of the Mailman School of Public Health
Director of the Robert N. Butler Aging Center
Senior Vice President, Columbia University Irving Medical Center
Featuring Panelists
Katrina Armstrong, MD
Dean of the Vagelos College of Physicians and Surgeons
Executive Vice President of Health and Biomedical Sciences, Columbia University
Gary W. Miller, PhD
Vice Dean for Research Strategy and Innovation
Professor of Environmental Health Sciences (in Molecular Pharmacology and Therapeutics)
Mailman School of Public Health
Nsikan Akpan, PhD
Health and Science Editor, WNYC/Gothamist
Biography
Dr. Nsikan Akpan runs the health and science desk at WNYC/Gothamist, as its editor. He was previously a science editor at National Geographic, overseeing its COVID-19 coverage in addition to other topics in science, health, and technology. Before joining National Geographic, Dr. Akpan worked for more than four years at PBS NewsHour, where he co-created an award-winning video series named “ScienceScope.” Dr. Akpan shared a 2020 Emmy for the PBS NewsHour series “Stopping a Killer Pandemic” and in 2019 received a George Foster Peabody Award for the PBS NewsHour series “The Plastic Problem.” He has also worked for NPR, Science News Magazine, Science Magazine, the Santa Cruz Sentinel and as a writer at the Center for Infection and Immunity at Columbia University. He holds a doctorate in pathobiology from Columbia University and is an alum of the science communication program at the University of California, Santa Cruz.
January 25, 2023
“The Importance of Well-Being for Delivering Exceptional Performance”
Featuring Panelists
Carolyn Everson
Board Director, The Walt Disney Company and The Coca-Cola Company
Member, VP&S Board of Advisors
Biography
Carolyn Everson, a member of the Vagelos College of Physicians and Surgeons Board of Advisors, is a business leader with extensive experience in media and consumer-facing companies. She joined Permira as a senior advisor in January and before that she most recently served as president of Instacart. Prior to that role, Ms. Everson was vice president for global marketing solutions at Meta from 2011-2021. She has held additional senior leadership roles in media and technology, including as corporate vice president of Microsoft’s Global Advertising Sales, Strategy & Marketing and chief operating officer and executive vice president for advertising sales at MTV Networks. Before joining MTV Networks, Ms. Everson worked at PriMedia and Walt Disney Imagineering.
She serves on the boards of the Walt Disney Company, the Coca Cola Company, Villanova University, and the Humane Society of the United States. She is a member of the Council on Foreign Relations. Ms. Everson earned a bachelor’s degree in liberal arts and communications from Villanova University and a master’s degree in business administration from Harvard Business School.
Katrina Armstrong, MD
Dean of the Vagelos College of Physicians and Surgeons
Executive Vice President of Health and Biomedical Sciences, Columbia University
Moderated by
Lou Baptista, MD
Chief Well-Being Officer, CUIMC
Vice-Chair, Department of Psychiatry
Vagelos College of Physicians and Surgeons
January 26, 2022
"Longevity Research and the Clinic: the geroscience hypothesis"
Featuring
Eric Verdin, MD
President and CEO
The Buck Institute for Research on Aging
Biography
Dr. Verdin is president and chief executive officer of the Buck Institute for Research on Aging. The Buck Institute, located in the San Francisco Bay Area, is globally recognized as the pioneer and leader in the field of research on aging, the No. 1 risk factor for chronic disease.
A native of Belgium, Dr. Verdin received his MD degree from the University of Liege and completed additional clinical and research training at Harvard Medical School. He has held faculty positions at the University of Brussels, the National Institutes of Health (NIH), and the Gladstone Institute at the University of California San Francisco (UCSF). Dr. Verdin is currently adjunct professor of medicine at UCSF and adjunct professor at the University of Southern California (USC).
Dr. Verdin studies how metabolism, diet, and small molecules impact epigenetic regulatory mechanisms and, thereby, the aging process and its associated diseases. He is a highly cited scientist and has been recognized for his research with multiple awards including a fellowship from the American Association for the Advancement of Science and election to the American Society for Clinical Investigation, the Association of American Physicians, and Belgium’s Royal Academy of Medicine.
Followed by a conversation with
Linda P. Fried, MD, MPH
Dean of the Mailman School of Public Health
Director of the Robert N. Butler Columbia Aging Center
Senior Vice President, Columbia University Irving Medical Center
October 27, 2021
"Infection Prevention and Control in Nursing Homes"
Featuring
Pat W. Stone, PhD, RN, FAAN, CIC
Centennial Professor of Health Policy
Director of the Center for Health Policy
Columbia University School of Nursing
Biography
Dr. Stone is the Centennial Professor of Health Policy in the Columbia University School of Nursing. She directs the School of Nursing’s Center for Health Policy and the NIH-funded Center for Improving Palliative Care for Vulnerable Adults with Multiple Chronic Conditions. For the past two decades, most of her research has focused on the prevention of infections in vulnerable adults across health care settings. Since 2010, she has led an interdisciplinary team that has conducted multiple NIH and Centers for Disease Control and Prevention (CDC)-funded studies examining nursing home capacity for infection prevention. These mixed methods studies use multiple data sources including national surveys linked to Centers for Medicare and Medicaid Services data (i.e., Minimum Data Set and Medicare Claims) and the CDC’s National Healthcare Safety Network data. Her team also has engaged nursing home stakeholders and conducted qualitative interviews. The results of these studies have informed national regulations for nursing homes to have trained infection preventionists. Because many nursing home residents have serious illness, Dr. Stone is also interested in the integration of infection management and palliative care at the end-of-life. She is the current editor-in-chief of the American Journal of Infection Control and an elected member of the National Academy of Medicine.
April 22, 2021
"Pandemic Preparedness: A Public Health Perspective"
Featuring panelists
Wafaa El-Sadr, MD, MPH, MPA
University Professor
Dr. Mathilde Krim-amfAR Professor of Global Health (in Epidemiology)
Director, ICAP at Columbia University
W. Ian Lipkin, MD
John Snow Professor of Epidemiology
Professor of Neurology and of Pathology & Cell Biology
Director, Center for Infection and Immunity
Jeffrey Shaman, PhD
Professor of Environmental Health Sciences (in the International Research Institute for Climate and Society/Earth Institute)
Director, Climate and Health Program
Moderated by
Linda P. Fried, MD, MPH
DeLamar Professor of Public Health Practice
Professor of Epidemiology and of Medicine
Dean, Mailman School of Public Health
Senior Vice President, Columbia University Irving Medical Center
March 1, 2021
"Increased Resistance of New Circulating SARS-CoV-2 Variants to Antibody Neutralization"
Featuring
David D. Ho, MD
Clyde ’56 and Helen Wu Professor of Medicine
Director, Aaron Diamond AIDS Research Center
Director, Wu Family China Center
Biography
Dr. Ho is the Clyde’56 and Helen Wu Professor of Medicine, founding scientific director of the Aaron Diamond AIDS Research Center, and director of the Wu Family China Center for Health Initiatives at Columbia University Vagelos College of Physicians and Surgeons. He received degrees from California Institute of Technology and Harvard Medical School.
Dr. Ho has been at the forefront of AIDS research for 39 years, publishing over 400 papers. His elegant studies unraveled the dynamic nature of HIV replication in vivo and revolutionized our basic understanding of a disease that took the lives of so many. He championed combination antiretroviral therapy that resulted in unprecedented management of HIV in patients, transforming a disease that meant almost certain death into a chronic condition for more than 25 million individuals worldwide. His research team is now devoting considerable effort to vaccine and antibody research directed at halting or slowing the spread of AIDS. After working on the SARS virus, he has turned his work now to developing drugs and antibodies to fight the new coronavirus.
Dr. Ho has received 14 honorary doctorates, including one from Columbia University. He was named Time Magazine’s Man of the Year in 1996 and received a Presidential Citizen Medal in 2001. He was inducted into the California Hall of Fame, recognized by the Kingdom of Thailand with the Prince Mahidol Award in Medicine, and given the Distinguished Alumni Award by Caltech. He is a member of the National Academy of Medicine as well as the Chinese Academy of Engineering.